Citation

Khanam A, Dar SA, Wani ZA. J. Med. Sci. (Taipei Taiwan) 2021; 41(5): 253-255.

Copyright

(Copyright © 2021, Wolters Kluwer MedKnow)

DOI

10.4103/jmedsci.jmedsci_191_20

PMID

unavailable

Abstract

Cyproheptadine hydrochloride(CH)- and dexamethasone-induced obsessive-compulsive symptomatology with suicide is extremely rare. We describe the case of a 20-year-old lean male who developed obsessive-compulsive symptoms and suicidality within a week of the use of CH and dexamethasone. There was complete resolution of symptoms after stopping the offending agent. Ashort trial of selective serotonin reuptake inhibitor was given for the rapid improvement of symptoms. © 2021 Journal of Medical Sciences.

Language: en

Keywords

adult; human; male; case report; anxiety; suicide attempt; suicidal behavior; acne; Obsessive-compulsive symptoms; mental disease; clinical article; fluoxetine; serotonin uptake inhibitor; quetiapine; REM sleep; alprazolam; olanzapine; drug withdrawal; lorazepam; delirium; corticosteroid; dexamethasone; alanine aminotransferase; aspartate aminotransferase; clonazepam; organophosphorus compound; remission; obsessive compulsive disorder; Dexamethasone; cyproheptadine; proton pump inhibitor; calcium blood level; Article; drug substitution; Yale Brown Obsessive Compulsive Scale; parathyroid hormone; Cyproheptadine hydrochloride